688799.SH
华纳药厂
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 43.33
−0.73%Aug 31, 2026, 11:20 UTC
Warner Pharmaceutical received a drug registration certificate approved by the National Medical Products Administration for Loxoprofen Sodium Patch, used for anti-inflammatory and analgesic purposes, available in two specifications.
Source:Aug 24, 2026, 10:46 UTC
Hua Na Pharmaceutical increased the investment budget for its wholly-owned subsidiary Zhigen Pharmaceutical's Phase I high-end API and intermediate green manufacturing base project from no more than 650 million yuan to no more than 800 million yuan.
Source:Jul 17, 2026, 07:59 UTC
Hunan Warner Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration for a supplementary application to change the marketing authorization holder of Hydroxychloroquine Sulfate Tablets.
Source: